---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-116439"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2025-05-09T23:59:59+00:00"
generated_at: "2026-05-22T01:58:22.811310+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers prices $870M 0.00% convertible notes due 2030 for global expansion and AI investment

## Summary
- Initial $450M offering upsized to $870M; initial purchasers option for additional $130M.
- Zero-coupon notes due 2030; initial conversion price ~$70.67/share (37.5% premium over $51.40 close).
- Net proceeds est. $842.7M ($968.8M if full exercise); ~$41.6M for capped call transactions.
- Proceeds for global expansion (organic + M&A), AI/data platform; no material acquisition agreements yet.
- New CTO Mo Elshenawy leading tech team to develop AI tools and personalized treatments.

## SEC filing metadata
- accession: 0001193125-25-116439
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2025-05-09T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000119312525116439/0001193125-25-116439-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000119312525116439/d905005d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-116439
- JSON: https://secwatch.observer/filing/0001193125-25-116439.json
- Plain text: https://secwatch.observer/filing/0001193125-25-116439.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.